Clinical Trial Update: Safety of Ramelteon in Subjects With Mild to Moderate Obstructive Sleep Apnea [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating the safety of ramelteon in adults with mild to moderate obstructive sleep apnea has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Obstructive Sleep Apnea

Drugs mentioned

• Ramelteon (Rozerem) (ramelteon)

Snippet

Sponsor: Takeda | Conditions: Sleep Apnea, Obstructive | Phase 2 | Status: COMPLETED